Chidozie Anyaegbu

Mr, Dr

  • The University of Western Australia (M507), 35 Stirling Highway,

    6009 Perth

    Australia

  • 22 Citations
  • 3 h-Index
20142019
If you made any changes in Pure these will be visible here soon.

Personal profile

Roles and responsibilities

Postdoctoral Research Fellow

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 20 Similar Profiles
Cross-Priming Medicine & Life Sciences
Neoplasm Antigens Medicine & Life Sciences
Nuclear Antigens Medicine & Life Sciences
Chemotherapy Chemical Compounds
Neoplasms Medicine & Life Sciences
Chemoradiotherapy Medicine & Life Sciences
Regulatory T-Lymphocytes Medicine & Life Sciences
Rectal Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2014 2017

  • 22 Citations
  • 3 h-Index
  • 2 Article
  • 1 Abstract/Meeting Abstract
  • 1 Letter
  • 1 Doctoral Thesis

The Cancer Stem-Like Cell Marker SOX2 is Prognostic and May Predict Response to Chemotherapy in Colon Cancer

Miller, T. J., McCoy, M. J., Anyaegbu, C., Cheah, K., Hemmings, C., Bulsara, M., Iacopetta, B. & Platell, C. F., Nov 2017, In : Asia-Pacific Journal of Clinical Oncology. 13, p. 73-74 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

8 Citations (Scopus)
Open Access
Chemoradiotherapy
Regulatory T-Lymphocytes
Rectal Neoplasms
Cell Count
Neoplasms

The effect of tumour antigen properties on the efficiency of cross-presentation

Anyaegbu, C. C., 2016, (Unpublished)

Research output: ThesisDoctoral Thesis

File
Cross-Priming
Neoplasm Antigens
Nuclear Antigens
Neoplasms
Immunotherapy
11 Citations (Scopus)

Chemotherapy enhances cross-presentation of nuclear tumor antigens

Anyaegbu, C., Lake, R., Heel, K., Robinson, B. & Fisher, S., 22 Sep 2014, In : PLoS One. 9, 9, p. e107894

Research output: Contribution to journalArticle

Open Access
Cross-Priming
Nuclear Antigens
Chemotherapy
Neoplasm Antigens
drug therapy

Projects 2018 2019